EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $354 | -99.9% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $347,000 | +1.5% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $342,000 | 0.0% | 35,000 | 0.0% | 0.01% | +8.3% |
| Q1 2022 | $342,000 | +0.6% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $340,000 | 0.0% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $340,000 | +0.6% | 35,000 | 0.0% | 0.01% | +9.1% |
| Q2 2021 | $338,000 | – | 35,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |